Life Insurance Quotes

Bone drug helping women with breast cancer

12/13/11

A recent study by doctors at the University of Vienna revealed that the bone drugs they prescribed to women with breast cancer boosted survival rates.

Dr. Michael Gnant of Austria's Medical University of Vienna, who was the lead researcher in the study, presented his findings in San Antonio at the recent Breast Cancer Symposium.

Dr. Gnant stated that the benefits of the bone drug persist long after treatment ends. After receiving treatment once every six months for three years, doctors were amazed with the positive outcome.

The study showed that women who received the bone drug Zometa were 37 percent less likely to die than women with breast cancer who didn't receive the treatment, leading cancer specialists to call for the drug to be offered to all patients. The study reported that there were 33 deaths among women who took the drug and 49 deaths among the group that did not.

Pills similiar to Zometa, such as Fosamax, Boniva and Actonel, have been prescribed as daily treatments for osteoporosis, but the study suggests another use for them as cancer therapies.

A vaccine developed recently by researchers at the University of Georgia and the Mayo Clinic has also shown great promise as a cancer treatment, the Daily Mail recently reported.

While scientists continue to make breakthroughs in treating cancer, the disease still claims many lives each year. Life insurance is a dependable option to prepare for unforeseen circumstances that may arise in the future. 

Talk to an Advisor

A licensed insurance advisor can explain your options and help you choose the right life insurance for your needs.

Call: 1-800-823-4852

Chat: Live Advisor Chat

Sm

A few of the carriers we quote